Pharmacogenetics to prevent heparin-induced thrombocytopenia: what do we know?

per Karnes, Jason H
Publicat a Pharmacogenomics (2018)

Antihypertensive Medications: Benefits of BP Lowering and Hazards of Metabolic Effects

per Karnes, Jason H., Cooper-DeHoff, Rhonda M.
Publicat 2009

Reply to Non and Chang: Challenging the Role of Genetic Ancestry in Explaining Racial/Ethnic Health Disparities

per Karnes, Jason H., Schwantes-An, Tae-Hwi, Kittles, Rick
Publicat a Am J Respir Crit Care Med (2021)

Evolution of Next Generation Therapeutics: Past, Present, and Future of Precision Medicines

per Ramamoorthy, Anuradha, Karnes, Jason H., Finkel, Richard, Blanchard, Rebecca, Pacanowski, Michael
Publicat a Clin Transl Sci (2019)

Clinical and Genetic Factors Associated With Cutaneous Squamous Cell Carcinoma in Kidney and Heart Transplant Recipients

per Sanders, M. Lee, Karnes, Jason H., Denny, Josh C., Roden, Dan M., Ikizler, T. Alp, Birdwell, Kelly A.
Publicat a Transplant Direct (2015)

WARFARIN PHARMACOGENOMICS IN DIVERSE POPULATIONS

per Kaye, Justin B, Schultz, Lauren E, Steiner, Heidi E, Kittles, Rick A, Cavallari, Larisa H, Karnes, Jason H
Publicat a Pharmacotherapy (2017)

Factors Influencing Blood Pressure Response to Trandolapril Add-On Therapy in Patients Taking Verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study)

per Brunner, Martin, Cooper-DeHoff, Rhonda M., Gong, Yan, Karnes, Jason H., Langaee, Taimour Y., Pepine, Carl J., Johnson, Julie A.
Publicat 2007

From Big Data to Precision Medicine

per Hulsen, Tim, Jamuar, Saumya S., Moody, Alan R., Karnes, Jason H., Varga, Orsolya, Hedensted, Stine, Spreafico, Roberto, Hafler, David A., McKinney, Eoin F.
Publicat a Front Med (Lausanne) (2019)

Using Systems Approaches to Address Challenges for Clinical Implementation of Pharmacogenomics

per Karnes, Jason H, Van Driest, Sara, Bowton, Erica A, Weeke, Peter E, Mosley, Jonathan D, Peterson, Josh F, Denny, Joshua C, Roden, Dan M
Publicat 2013

Alteration in Fasting Glucose after Prolonged Treatment with a Thiazide Diuretic

per Karnes, Jason H, Gong, Yan, Arwood, Meghan J, Gums, John G, Hall, Karen, Limacher, Marian C, Johnson, Julie A, Cooper-DeHoff, Rhonda M
Publicat 2014

Psychological and Genetic Predictors of Pain Tolerance

per Patanwala, Asad E., Norwood, Charles, Steiner, Heidi, Morrison, Daniel, Li, May, Walsh, Keith, Martinez, Marina, Baker, Sarah E., Snyder, Eric M., Karnes, Jason H.
Publicat a Clin Transl Sci (2018)

Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions

per Karnes, Jason H, Miller, Matthew A., White, Katie D, Konvinse, Katherine, Pavlos, Rebecca, Redwood, Alec J, Peter, Jonny, Lehloenya, Ranks, Mallal, Simon, Phillips, Elizabeth J
Publicat a Annu Rev Pharmacol Toxicol (2018)

IMPACT OF TCF7L2 SINGLE NUCLEOTIDE POLYMORPHISMS ON HYDROCHLOROTHIAZIDE-INDUCED DIABETES

per Karnes, Jason H, Gong, Yan, Pacanowski, Michael A, McDonough, Caitrin W, Arwood, Meghan J, Langaee, Taimour Y, Pepine, Carl J, Johnson, Julie A, Cooper-DeHoff, Rhonda M
Publicat 2013

Comparison of HLA allelic imputation programs

per Karnes, Jason H., Shaffer, Christian M., Bastarache, Lisa, Gaudieri, Silvana, Glazer, Andrew M., Steiner, Heidi E., Mosley, Jonathan D., Mallal, Simon, Denny, Joshua C., Phillips, Elizabeth J., Roden, Dan M.
Publicat a PLoS One (2017)

Single nucleotide polymorphisms in the MYLKP1 pseudogene are associated with increased colon cancer risk in African Americans

per Lynn, Heather, Sun, Xiaoguang, Ayshiev, Djanybek, Siegler, Jessica H., Rizzo, Alicia N., Karnes, Jason H., Gonzales Garay, Manuel, Wang, Ting, Casanova, Nancy, Camp, Sara M., Ellis, Nathan A., Garcia, Joe GN
Publicat a PLoS One (2018)

Influence of HLA alleles and KIR types on Heparin-Induced Thrombocytopenia

per Karnes, Jason H, Shaffer, Christian M, Cronin, Robert, Bastarache, Lisa, Gaudieri, Silvana, James, Ian, Pavlos, Rebecca, Steiner, Heidi, Mosley, Jonathan D, Mallal, Simon, Denny, Joshua C, Phillips, Elizabeth J, Roden, Dan M
Publicat a Pharmacotherapy (2017)

Lack of association of the <it>HMGA1</it> IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohort

per Karnes Jason H, Langaee Taimour Y, McDonough Caitrin W, Chang Shin-Wen, Ramos Miguel, Catlin Jr James R, Casanova Octavio E, Gong Yan, Pepine Carl J, Johnson Julie A, Cooper-DeHoff Rhonda M
Publicat 2013-01-01

Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohort

per Karnes, Jason H, Langaee, Taimour Y, McDonough, Caitrin W, Chang, Shin-Wen, Ramos, Miguel, Catlin Jr, James R, Casanova, Octavio E, Gong, Yan, Pepine, Carl J, Johnson, Julie A, Cooper-DeHoff, Rhonda M
Publicat 2013

PROX1 GENE VARIANT IS ASSOCIATED WITH FASTING GLUCOSE CHANGE AFTER ANTIHYPERTENSIVE TREATMENT

per Gong, Yan, McDonough, Caitrin W, Beitelshees, Amber L, Karnes, Jason H, O’Connell, Jeffrey R., Turner, Stephen T, Chapman, Arlene B, Gums, John G, Bailey, Kent R, Boerwinkle, Eric, Johnson, Julie A, Cooper-DeHoff, Rhonda M
Publicat 2013

Identifying genetically driven clinical phenotypes using linear mixed models

per Mosley, Jonathan D., Witte, John S., Larkin, Emma K., Bastarache, Lisa, Shaffer, Christian M., Karnes, Jason H., Stein, C. Michael, Phillips, Elizabeth, Hebbring, Scott J., Brilliant, Murray H., Mayer, John, Ye, Zhan, Roden, Dan M., Denny, Joshua C.
Publicat a Nat Commun (2016)